Jing Chen
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 9
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 15
- Pharmaceutical Science top 1%
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 31
- Advanced biosensing and bioanalysis techniques 12
- Glycosylation and Glycoproteins Research 11
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 24
-
- Pancreatic function and diabetes 23
-
- Pharmacological Effects of Natural Compounds 11
Jing Chen
256 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Molecular Medicine 736
- Biomaterials 1.4k
- Pharmaceutical Science 385
- Molecular Biology 2.3k
- Biomedical Engineering 1.4k
Countries citing papers authored by Jing Chen
This map shows the geographic impact of Jing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Chen more than expected).
Fields of papers citing papers by Jing Chen
This network shows the impact of papers produced by Jing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Chen. The network helps show where Jing Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 13 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 23 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 0 | |
| 11 | 2021 | 20 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 38 | |
| 14 | 2021 | 51 | |
| 15 | 2020 | 8 | |
| 16 | 2019 | 89 | |
| 17 | 2017 | 59 | |
| 18 | 2016 | 0 | |
| 19 | 2012 | 2 | |
| 20 | ACCELERATED TYPE 1 DIABETES IN CD38-DEFICIENT NOD MICE THROUGH A FURTHER LOSS OF DISEASE PROTECTIVE NKT CELLS AND MATURE DENDRITIC CELLS | 2005 | 1 |
About Jing Chen
Jing Chen is a scholar working on Molecular Medicine, Biomaterials and Pharmacology, having authored 274 papers that have together received 6.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (31 papers), Nanoplatforms for cancer theranostics (24 papers), Pancreatic function and diabetes (23 papers), Nanoparticle-Based Drug Delivery (15 papers), Advanced biosensing and bioanalysis techniques (12 papers), Pharmacological Effects of Natural Compounds (11 papers), Glycosylation and Glycoproteins Research (11 papers) and Antibiotic Resistance in Bacteria (9 papers). The work is most often cited by research in Molecular Medicine (736 citations), Biomaterials (1.4k citations) and Pharmaceutical Science (385 citations). Jing Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Chao Deng, Zhiyuan Zhong, Erik J. Suuronen, Yanjiao Jiang, Minglin Ma, Yue Tang, Hui Zhang, Xi Wang, Jianzhong Du and Qiuming Liu. Their work appears in journals such as International Journal of Biological Macromolecules, ACS Applied Materials & Interfaces, International Journal of Pharmaceutics, Biomaterials and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.